Malvidin

Malvidin

SCHEMBL308690

COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O.[Cl-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Malvidin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 1.00
MAOA P21397 2/20 1.00
CD38 P28907 9/20 0.97
ALDH1A1 P00352 1/20 0.69
TSHR P16473 1/20 0.69
HSD17B10 Q99714 1/20 0.69
GLO1 Q04760 5/20 0.68
SNCA P37840 3/20 0.68
EGFR P00533 2/20 0.68
KDR P35968 2/20 0.68
EP300 Q09472 2/20 0.68
CREBBP Q92793 2/20 0.68
OR51E2 Q9H255 2/20 0.60
F2 P00734 1/20 0.55
NR1H2 P55055 1/20 0.55
NR1H3 Q13133 1/20 0.55
AKR1B1 P15121 1/20 0.39
MAPK8 P45983 1/20 0.39
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malvidin SCHEMBL29640416 1.00 DPP4 (1.00) DPP4MAOACD38ALDH1A1TSHR
Malvidin SCHEMBL30683334 1.00 DPP4 (1.00) DPP4MAOACD38ALDH1A1TSHR
Malvidin SCHEMBL29406694 0.99 CD38 (1.00) DPP4MAOACD38ALDH1A1TSHR
Malvidin SCHEMBL21739 0.99 CD38 (1.00) DPP4MAOACD38ALDH1A1TSHR
Petunidin SCHEMBL21649 0.96 CD38 (0.97) DPP4MAOACD38ALDH1A1TSHR
Petunidin SCHEMBL29947229 0.96 CD38 (0.97) DPP4MAOACD38ALDH1A1TSHR
Petunidin SCHEMBL30683343 0.96 CD38 (0.97) DPP4MAOACD38ALDH1A1TSHR
Petunidin SCHEMBL9120043 0.94 CD38 (0.95) DPP4MAOACD38ALDH1A1TSHR
Petunidin SCHEMBL8411777 0.94 CD38 (0.95) DPP4MAOACD38ALDH1A1TSHR
Petunidin SCHEMBL21650 0.94 CD38 (1.00) DPP4MAOACD38ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4267659-B1 SILOXANE-IMIDE COPOLYMER AND ADDITION CURABLE COMPOSITION COMPRISING SAME MOMENTIVE PERFORMANCE MAT INC (US) 2026-03-25 EP claimed
US-12568120-B2 Image forming device restricting transmission of email having scan data to email address when memory stores no domain matching domain of the mail address BROTHER KOGYO KABUSHIKI KAISHA (JP) 2026-03-03 US claimed
CN-120021468-A Seed posture correcting element of belt type soybean high-speed seed guiding device and design method thereof 黑龙江八一农垦大学 2025-05-23 CN claimed
EP-3940080-B1 INVENTION RELATING TO THE ANALYSIS OF AT LEAST ONE CHEMICAL COMPOUND BY SIMULATING AT LEAST ONE METABOLISATION PROCESS JUSTUS LIEBIG UNIV GIESSEN KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) 2025-04-02 EP claimed
CN-119692093-A Method for dimension design and thermal bridge influence prediction of multilayer composite connecting piece 黑龙江省建工集团有限责任公司 2025-03-25 CN claimed
CN-119616253-A Multilayer prestress tension reinforcement system and construction method thereof 卡本科技集团股份有限公司 2025-03-14 CN claimed
WO-2025048653-A1 ANALYTICAL METHODS AND RELATED COMPOSITIONS AND USES OTAGO INNOVATION LIMITED (NZ) 2025-03-06 WO claimed
CN-119468532-A Peltier automatic switching cold and hot regulating system and method 青岛明德环保仪器有限公司 2025-02-18 CN claimed
EP-3805299-B1 THREE-DIMENSIONAL SOLID POLYMERIC FOAMS AND A MICROFLUIDIC PROCESS TO DESIGN THEM PARIS SCIENCES ET LETTRES (FR) 2024-12-04 EP claimed
CN-118914413-A Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi 海南省农业科学院三亚研究院(海南省实验动物研究中心) 2024-11-08 CN claimed
EP-0290442-A4 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. CHEMEX PHARMACEUTICALS INC (US) 1990-07-03 EP claimed
EP-0338189-A2 Method of producing affin-enzymatic compounds, for the visual detection of cholesterol on the surface of the skin of a patient, based on a detecting agent with an affinity for cholesterol and a visualisation agent 2860601 Canada Inc. (CN) 1989-10-25 EP claimed
EP-0290442-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-11-17 EP claimed
WO-1988003805-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-06-02 WO claimed
EP-0183724-A1 INTEGRATED CIRCUIT PACKAGE. AMERICAN TELEPHONE & TELEGRAPH (US) 1986-06-11 EP claimed
WO-1985005735-A1 INTEGRATED CIRCUIT PACKAGE AMERICAN TELEPHONE & TELEGRAPH COMPANY (US) 1985-12-19 WO claimed
EP-0015436-B1 PROCESS FOR THE STEREOSPECIFIC PREPARATION OF COMPOUNDS OF THE VITAMIN K1- AND K2-SERIES, AS WELL AS NEW STARTING MATERIALS FOR THE PROCESS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-02-03 EP claimed
EP-0003583-B1 COMPOSITIONS FOR CYTOCHEMICAL INVESTIGATION, THEIR USE AND METHOD FOR THE DETECTION OF STEROID HORMONE RECEPTORS IN HUMAN TISSUES Lee, Sin Hang (US) 1981-12-02 EP claimed
US-4284707-A Photocurable light-sensitive composition SOMAR MANUFACTURING CO., LTD. (JP) 1981-08-18 US claimed
EP-0015436-A1 Process for the stereospecific preparation of compounds of the vitamin K1- and K2-series, as well as new starting materials for the process F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1980-09-17 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12568120-B2 Image forming device restricting transmission of email having scan data to email address when memory stores no domain matching domain of the mail address ERLIN2, ERLIN1, MICA DPP4 2602/4885MAOA 4353/4885CD38 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.